Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The Company also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.


CSE:DOSE - Post by User

Comment by lscfaon Jan 30, 2023 11:41am
107 Views
Post# 35254062

RE:Fins on sedar

RE:Fins on sedarMay and Nov qtrs posted this am

 

Q ending 

Revenue

Gross profit

Margin

Nov 22

305,629

227,485

74.4%

Aug 22

133,554

84,874

63.6%

May 22

61,766

31,393

50.8%

Feb 22

145,804

(83,739)

(57.4%)

Nov 21

457,724

359,173

78.5%

Aug 21

324,640

291,942

89.9%

May 21 (restated)

823,748

777,421

94.4%

Feb 21 (restated)

635,914

571,471

89.9%

Nov 20

126,471

124,987

98.8%

Aug 20

3,579

3,155

88.2%

May 20

237

237

100.0%

 

<< Previous
Bullboard Posts
Next >>